These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6959488)

  • 21. [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children].
    Kang H; Zhang YF; Jiao FY; Guo XY; Gao XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):537-9. PubMed ID: 19650984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
    Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
    J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tourette syndrome. New aspects on pharmacological treatment].
    Aabech HS
    Tidsskr Nor Laegeforen; 1989 Mar; 109(9):961-3. PubMed ID: 2565050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tourette syndrome in the Chinese: a follow-up of 15 cases.
    Mak FL; Chung SY; Lee P; Chen S
    Adv Neurol; 1982; 35():281-3. PubMed ID: 6959500
    [No Abstract]   [Full Text] [Related]  

  • 25. Visually evoked responses in Tourette syndrome.
    Domino EF; Piggott L; Demetriou S; Culbert J
    Adv Neurol; 1982; 35():115-20. PubMed ID: 6959484
    [No Abstract]   [Full Text] [Related]  

  • 26. Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
    Bourgoin S; Rostaing-Rigattieri S; Nguyen JP; Berberich E; Duvaldestin P; Fattaccini CM; Hamon M; Cesselin F
    Clin Neuropharmacol; 1999; 22(4):231-8. PubMed ID: 10442254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():433-6. PubMed ID: 6959521
    [No Abstract]   [Full Text] [Related]  

  • 28. New pharmacological approaches in the treatment of Tourette syndrome.
    Borison RL; Ang L; Chang S; Dysken M; Comaty JE; Davis JM
    Adv Neurol; 1982; 35():377-82. PubMed ID: 6756088
    [No Abstract]   [Full Text] [Related]  

  • 29. Heterogeneity and variability in Tourette syndrome.
    Caine ED; Polinsky RJ; Ludlow CL; Ebert MH; Nee LE
    Adv Neurol; 1982; 35():437-42. PubMed ID: 6959522
    [No Abstract]   [Full Text] [Related]  

  • 30. Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
    Oulis P; Karapoulios E; Masdrakis VG; Kouzoupis AV; Karakatsanis NA; Papageorgiou C; Papadimitriou GN; Soldatos CR
    World J Biol Psychiatry; 2008; 9(1):76-7. PubMed ID: 17853302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of Gilles de la Tourette Syndrome with haloperidol and clonidine].
    Fennig S; Bauer A; Kronnenberg Y
    Harefuah; 1984 May; 106(10):457-8. PubMed ID: 6590432
    [No Abstract]   [Full Text] [Related]  

  • 32. Clonidine in the treatment of Tourette syndrome: a review of data.
    Leckman JF; Cohen DJ; Detlor J; Young JG; Harcherik D; Shaywitz BA
    Adv Neurol; 1982; 35():391-401. PubMed ID: 6756089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of medications on regulation of body temperature of patients with Tourette syndrome.
    Kessler AR
    J Child Neurol; 2004 Mar; 19(3):220-4. PubMed ID: 15119484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
    Peterson BS
    J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiency.
    Stahl SM; Berger PA
    Biol Psychiatry; 1982 Sep; 17(9):1047-53. PubMed ID: 6128037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood choline and response to clonazepam and haloperidol in Tourette's syndrome.
    Merikangas JR; Merikangas KR; Kopp U; Hanin I
    Acta Psychiatr Scand; 1985 Oct; 72(4):395-9. PubMed ID: 3865498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR; Dougherty D; Sethuraman G; Vrindavanam N
    Biol Psychiatry; 1996 Nov; 40(10):1044-50. PubMed ID: 8915564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Roles of fluoxetine and haloperidol in mouse models of DOI-induced head twitch response].
    Yao Y; Ma HW; Lu Y; Dai XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):469-72. PubMed ID: 17937861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.